Results 141 to 148 of about 151,952 (148)
Some of the next articles are maybe not open access.

Cactus pear (Opuntia ficus-indica) juice fermented with autochthonous Lactobacillus plantarum S-811.

Food & Function, 2019
The present study aimed at investigating the lactic fermentation of cactus pear (Opuntia ficus-indica) fruit juice with the autochthonous and potentially probiotic strain Lactobacillus plantarum S-811. L.
Hernán E. Verón   +7 more
semanticscholar   +1 more source

Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients

British Journal of Ophthalmology, 2018
Aims To determine the demographic and morphological characteristics of patients with central serous chorioretinopathy (CSC) and describe risk factors for CSC.
M. Ersoz   +4 more
semanticscholar   +1 more source

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

The Lancet, 2023
Y. Janjigian   +19 more
semanticscholar   +1 more source

KEYNOTE-811: pembrolizumab in advanced HER2+ gastric cancer

Nature reviews: Gastroenterology & hepatology, 2022
J. Hindson
semanticscholar   +1 more source

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

The Lancet
Austin E. Schumacher   +499 more
semanticscholar   +1 more source

LBA-4 Initial data from the phase 3 KEYNOTE-811 study of trastuzumab and chemotherapy with or without pembrolizumab for HER2-positive metastatic gastric or gastroesophageal junction (G/GEJ) cancer

Annals of Oncology, 2021
Y. Janjigian   +18 more
semanticscholar   +1 more source

1400O Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma

Annals of Oncology
Y. Janjigian   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy